前收市價 | 24.23 |
開市 | 24.14 |
買盤 | 24.90 x 800 |
賣出價 | 25.19 x 1100 |
今日波幅 | 24.01 - 25.11 |
52 週波幅 | 21.60 - 77.50 |
成交量 | |
平均成交量 | 4,290,518 |
市值 | 4.058B |
Beta 值 (5 年,每月) | 1.03 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -5.94 |
業績公佈日 | 2023年4月25日 - 2023年5月01日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 31.68 |
With the tech sector selling off throughout 2022 and attempting to make a recovery this year, it may seem to some that now is the time to look for tech stocks to buy, rather than tech stocks to sell. However, while there may be a case to be made for buying back into FAANG components like Facebook parent Meta Platforms (NASDAQ:META), or even into more speculative tech growth stories with near-term catalysts, like SoFi Technologies (NASDAQ:SOFI), there are still plenty of hard-hit tech stocks that
Markets will exploit investors who are too patient and forgiving on companies that are the value traps. These companies mask as deeply discounted companies that appear to have plenty of margin of safety and low risk. Those stocks are cheap for a reason. Their business model lacks a meaningful catalyst that will turn its fortunes around. Until that happens, the company’s revenue and corresponding earnings are at risk of getting worse. Investors become bagholders when they buy companies that are s
Teladoc Health Inc (NYSE: TDOC) shares are trading lower in Tuesday's after-hours session after the company reported fourth-quarter results and issued weak guidance. What Happened: Teladoc said fourth-quarter revenue increased 15% year-over-year to $637.71 million, which beat average analyst estimates of $633.65 million, according to Benzinga Pro. The company reported quarterly earnings of $23.49 per share due to non-cash goodwill impairment charges of $23.26 per share. Excluding the impairment